Hemorrhagic transformation after tissue plasminogen activator treatment in acute ischemic stroke
C Liu, J Xie, S Sun, H Li, T Li, C Jiang, X Chen… - Cellular and molecular …, 2022 - Springer
Hemorrhagic transformation (HT) is a common complication after thrombolysis with
recombinant tissue-type plasminogen activator (rt-PA) in ischemic stroke. In this article …
recombinant tissue-type plasminogen activator (rt-PA) in ischemic stroke. In this article …
[HTML][HTML] Middle cerebral artery stroke
TE Nogles, MA Galuska - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Identify the various potential etiologies of middle cerebral artery stroke.
Summarize the most important evaluations needed to diagnose a middle cerebral artery …
Summarize the most important evaluations needed to diagnose a middle cerebral artery …
[HTML][HTML] Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy
CM Diaz, EAG Corrales, SC Belnap, J Kline… - Cureus, 2021 - ncbi.nlm.nih.gov
Objective To assess anticoagulation (AC) timing and appropriateness in patients with acute
ischemic stroke (AIS) or transient ischemic attack (TIA) due to atrial fibrillation (AF) in a …
ischemic stroke (AIS) or transient ischemic attack (TIA) due to atrial fibrillation (AF) in a …
[PDF][PDF] АВТОМАТИЗИРОВАННАЯ ДЕТЕКЦИЯ СНИЖЕНИЯ ПЛОТНОСТИ ТКАНИ ПРИ ОСТРОМ ИШЕМИЧЕСКОМ ИНСУЛЬТЕ НА ОСНОВЕ НЕКОНТРАСТНЫХ …
М САЙФУЛЛАКЫЗЫ, АС ЖУСУПОВА… - КАЗАХСКОГО … - vestnik.kaznmu.edu.kz
Аннотация Введение. Острая ишемия головного мозга (ишемический инсульт) остается
одной из ведущих причин инвалидизации и летальности во всём мире. Неконтрастная …
одной из ведущих причин инвалидизации и летальности во всём мире. Неконтрастная …
[PDF][PDF] Timing of anticoagulation therapy in patients admitted with a primary diagnosis of ischemic stroke or transient ischemic attack due to non-valvular atrial …
CM Diaz, EG Corrales, FDLR La Rosa, H Clarke… - 2019 - baptisthealth.elsevierpure.com
Claudia Martin Diaz, PharmD; Eduardo A. Guizan Corrales, PharmD; Felipe De Los Rios La
Rosa, MD; Heidi Clarke, PharmD, BCCCP; Jonathan Kline, PharmD, BCCCP; Sylvia …
Rosa, MD; Heidi Clarke, PharmD, BCCCP; Jonathan Kline, PharmD, BCCCP; Sylvia …
[PDF][PDF] Timing of anticoagulation therapy in patients admitted with a primary diagnosis of ischemic stroke or transient ischemic attack due to non-valvular atrial …
C Martin Diaz, E Guizan Corrales… - 2019 - scholarlycommons.baptisthealth.net
Claudia Martin Diaz, PharmD; Eduardo A. Guizan Corrales, PharmD; Felipe De Los Rios La
Rosa, MD; Heidi Clarke, PharmD, BCCCP; Jonathan Kline, PharmD, BCCCP; Sylvia …
Rosa, MD; Heidi Clarke, PharmD, BCCCP; Jonathan Kline, PharmD, BCCCP; Sylvia …
[HTML][HTML] CITATION CODES
NO CASE - 2022 - casemine.com
That the opposite parties be directed to pay Rs. 9,912,512.00 (Ninety nine lakhs twelve
thousands five hundred and twelve) as cost/expenditure etc as mentioned in para 39 of the …
thousands five hundred and twelve) as cost/expenditure etc as mentioned in para 39 of the …